dc.creatorde Souza, Cinthia Madeira
dc.creatorVisacri, Marília Berlofa
dc.creatorFerrari, Graziele Baldan
dc.creatorTuan, Bruna Taliani
dc.creatorCosta, Anna Paula Lourenço
dc.creatorBarbosa, Cristina Rosa
dc.creatorLima, Carmen Silvia P
dc.creatorMazzola, Priscila Gava
dc.creatorMoriel, Patrícia
dc.date2015-Jan
dc.date2015-11-27T13:45:51Z
dc.date2015-11-27T13:45:51Z
dc.date.accessioned2018-03-29T01:23:10Z
dc.date.available2018-03-29T01:23:10Z
dc.identifierThe International Journal Of Pharmacy Practice. , 2015-Jan.
dc.identifier2042-7174
dc.identifier10.1111/ijpp.12169
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/25572714
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/202025
dc.identifier25572714
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1302258
dc.descriptionThis study aims to evaluate the frequency and severity of nausea and vomiting using two different instruments and relate them to quality of life (QOL) in patients with cancer receiving antineoplastic treatment. Severity of chemotherapy-induced nausea and vomiting (CINV) was measured by Common Terminology Criteria for Adverse Events (CTCAE) and a numerical scale. QOL was assessed using the Functional Assessment of Cancer Therapy-General questionnaire. Of the 50 patients studied, 60.0% reported nausea (40.0% CTCAE grade 1; 66.7% moderate intensity on numerical scale) and 30.0% reported vomiting (46.7% CTCAE grades 1 and 2, each; 66.7% moderate intensity on numerical scale). CINV did not influence overall QOL. The frequency of CINV was high. There was no association between nausea/vomiting and overall QOL.
dc.description
dc.description
dc.languageeng
dc.relationThe International Journal Of Pharmacy Practice
dc.relationInt J Pharm Pract
dc.rightsfechado
dc.rights© 2015 Royal Pharmaceutical Society.
dc.sourcePubMed
dc.subjectAntineoplastic Treatment
dc.subjectNausea
dc.subjectPharmacists
dc.subjectQuality Of Life
dc.subjectVomiting
dc.titleNausea, Vomiting And Quality Of Life Of Patients With Cancer Undergoing Antineoplastic Treatment: An Evaluation By Pharmacists.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución